Balentine LLC’s Express Scripts Holding Company ESRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q1
Sell
-77
Closed -$6K 608
2017
Q4
$6K Sell
77
-6
-7% -$384 ﹤0.01% 507
2017
Q3
$5K Buy
83
+6
+8% +$373 ﹤0.01% 527
2017
Q2
$5K Hold
77
﹤0.01% 501
2017
Q1
$5K Sell
77
-2,166
-97% -$149K ﹤0.01% 477
2016
Q4
$154K Sell
2,243
-1,296
-37% -$92.9K 0.02% 118
2016
Q3
$250K Hold
3,539
0.03% 79
2016
Q2
$268K Sell
3,539
-283
-7% -$20.8K 0.05% 62
2016
Q1
$263K Hold
3,822
0.07% 45
2015
Q4
$334K Sell
3,822
-805
-17% -$69K 0.07% 43
2015
Q3
$375K Hold
4,627
0.07% 39
2015
Q2
$412K Sell
4,627
-990
-18% -$86.5K 0.07% 26
2015
Q1
$487K Buy
+5,617
New +$471K 0.09% 19

Other funds holding ESRX

Balentine LLC's ESRX Position: Q1 2018 in Review

Balentine LLC sold out of Express Scripts Holding Company (ESRX) in Q1 2018, closing a stake of 77 shares — an estimated $6K sold.

Balentine LLC first reported a position in ESRX in Q1 2015 and held it in 12 quarters. The position peaked at $487K in Q1 2015. 1,119 funds tracked by Wall St. Rank hold ESRX as of Q1 2018.

  • Balentine LLC reported no remaining Express Scripts Holding Company position as of Q1 2018 after selling out during the quarter.
  • Balentine LLC sold 77 Express Scripts Holding Company shares in Q1 2018, an estimated $6K.
  • Balentine LLC first reported a position in Express Scripts Holding Company in Q1 2015 and held it in 12 quarters.
  • Balentine LLC's Express Scripts Holding Company position peaked at $487K in Q1 2015.
  • 1,119 funds tracked by Wall St. Rank held Express Scripts Holding Company as of Q1 2018.

Based on Balentine LLC's 13F filing for Q1 2018, filed 16 May 2018.